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Abstract:  Background: HIV in-
fection affects virtually all sys-
tems of the body including the 
haematological system.  
Objective: To determine the 
prevalence of anaemia in HIV 
infected children and compare 
with apparently healthy HIV 
negative age-sex matched con-
trols.  
Design: Case control hospital-
based study. 
Methods: A total of 60 confirmed 
HIV infected antiretroviral naïve 
children and 60 HIV negative 
children were enrolled in a case 
control study of baseline haemato-
logical indices. In all cases, hae-
moglobin, total white blood cell 
count, neutrophils, lymphocytes 
and platelet counts were deter-
mined using SYSMEX XT- 2000i 
Haematologic auto-analyser. Chil-
dren with HIV/AIDS were classi-
fied according to clinical disease 
stages using the 2006 World 
Health Organization (WHO) stag-
ing criteria. Data was analysed 
using MINITAB 12.21 Atlanta 
USA statistical software. 
Result: Anaemia (˂ 110 g/L) was 
present in 88.0% of the HIV-
infected children, compared to 
15.0% of controls (p = 0.001). 
Mild anaemia (70 – 109 g/L) was 
observed in 85.0% of HIV-
infected children, compared to 
15.0% of controls. Moderate anae-
mia (50 – 69 g/L) was present in 
3.3% of HIV-infected children, but 
in none of the control. Leucopenia
(˂4 × 109/L) was seen in 11.6% of 
HIV-infected children and in 5.0% 
of controls. Neutropenia (˂1.5 × 
109/L) affected13% of infected 
children and 5% ofcontrols. Lym-
phocytopenia (˂1.2 × 109/L) was 
observed in 3.3% of infected chil-
dren but in none ofcontrols. Corre-
sponding figures for thrombocyto-
penia (˂ 100 × 109/L) were6.7% of 
HIV infected children and 1.7% of 
controls.  
Conclusion: All cells lines 
arereduced in HIV/AIDS and 
anaemia is the most frequent hae-
matological manifestation seen in 
HIV/AIDS infection. 
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Introduction 
 
The HIV/AIDS scourge is a serious threat to the physi-
cal, social and economic development of affected coun-
tries, particularly the low resource, under developd 
countries. Virtually all systems are affected in HIV in-
fection and the haematological system is one of the early 
systems affected, resulting in early death or impaired 
quality of life1,2. Cytopenias in HIV infection are gener-
ally caused by inadequate production due to suppression 
of bone marrow by the HIV through abnormal expres-
sion of cytokines and alteration of the bone marrow mi-
croenvironment2-4. Thrombocytopenia is caused by im-
mune-mediated destruction of platelets, in addition t  
inadequate platelet production4-8. Other causes of cyto-
penias include adverse effects of drug therapy and sec-
ondary effects of opportunistic infections and malignan-
cies2,4,6. Optimal management of the underlying HIV 
infection is essential to correcting these cytopenias, n 
addition to identifying precipitating factors and provid-
ing supportive care. Supportive care based on the lev l 
of severity may include the use of haematinics, erythro-
poietin, myeloid growth factors (GM-CSF) in addition 
to the judicious use of red blood cell transfusions in e-
vere cases8-11. This study was undertaken to determine 
the prevalence of anaemia in children presenting with 
HIV infection in comparison with apparently healthy 




Subjects and Methods 
 
The study was conducted between the months of  
November 2009 and April 2010. Sixty antiretroviral-
naïve, HIV positive children between the ages of 3 
months to 14 years referred to the Paediatric HIV clinic 
were enrolled, and sixtyage-sex matched HIV negative 
children in apparently good health, without any clini-
cally observed acute or chronic illness were enrolled as 
controls. Informed consent was secured from the par-
ents/guardians of all the patients. Ethical clearance was 
obtained from the Research and Ethics Committee of 
Aminu Kano Teaching Hospital (AKTH) before the 
study was commenced. 
Laboratory analyses were conducted at the Federal Min-
istry of Health (FMOH) approved specialist laboratoy 
of AKTH. Specimens for full blood count was analysed 
using the haematology auto-analyser SYSMEX XT – 
2000i. In an effort to exclude some common causes of 
anaemia, haemoglobin genotype, blood film for malari  
and stool microscopy for hookworm were done to ex-
clude subjects with sickle cell anaemia, malaria and 
hookworm infestation. 
 
Demographic data, haemoglobin level, total white blood 
cell count, absolute neutrophil and lymphocyte count, 
platelet count were obtained. . Children with HIV/AIDS 
were classified according to clinical disease stages using 
the 2006 World Health Organization (WHO) staging 
criteria. Anaemia was defined as haemoglobin (Hb) 
<110 g/L: 70 – 109g/L as mild anaemia, 50 – 69g/L as 
moderate and < 50 g/L as severe anaemia12. Leucopenia 
defined as a total white blood cell count of < 4 × 109 /
L13.  Neutropenia defined as an absolute neutrophil 
count (ANC) of < 1.5 × 109 /L.13Lymphocytopenia de-
fined as an absolute lymphocyte count of < 1.2 × 109 /L. 
13 Thrombocytopenia defined as a platelet count of < 




Data entry, analyses and validation were done using 
MINITAB 12.21 Atlanta USA statistical software. 
Quantitative variables were summarized using mean and 
standard deviation and means were compared using Stu-
dent’s – t-test. Chi-square test of statistical signif cance 
was used to compare categorical variables. Probability 







There were 39 males and 21 females in each group of 60
HIV-infected and 60 controls, giving a male: female 
ratio of 1.9:1. The mean age of the males and the fe-
males were 39.9 (±31.3) and 70.7 (±46.7) months re-
spectively. The mean weight in the HIV-infected group 
was 13.11 (±7.40) kg and that of control group was 
14.94 (±6.70) kg (p = 0.16). The mean height of the HIV
-infected group was also comparable to that of controls 
(90.5 ±23.0cmversus 91.2 ±22.0cm, p = 0.85). Based on 
WHO clinical staging, 35 (58.4%) of the HIV-infected 
children belonged to stages 1 and 2 while 25 (41.6%) 
belonged to stages 3 and 4. Anaemia was the  
commonest haematological abnormality observed  
Fig 1: Frequency of cytopenias in HIV positive and con-
trol children 
 
(Leuco= leucopenia, Neutro=neutropenia, Lympho= lympho-
cytopenia, Thrombo= thrombocytopenia) 
 
The prevalence of anaemia was significantly higher in 
HIV-affected children than in controls [53 (88.3%) ver-
sus 9 (15.0%), χ2 = 64.61 p = 0.001. 
In comparing the mean haemoglobin level between the 
HIV infected and controls, a significant difference was 
observed. Also the mean level of leucocytes, neutro-
phils, lymphocytes and platelets are lower in infected 
children than control (Table 2). 
 
Table 2: Haematological indices of HIV infected compared 
with HIV uninfected children 
WBC = white blood cell 






Anaemia was the most common identified haematologi-
cal manifestation of HIV infection affecting88% of HIV 
infected children and only 15% of controls. The high 
prevalence of anaemia observed is similar to that of 
Adetifa et al who reported 77.9% of anaemia in HIV 
infected children in Lagos15 and Ellaurie et al who  
reported 94% in infected infants in New York5. How-
ever, the findings in the current study are more lik ly 
reflective of myelosuppressive effects of HIV infection  
because other diseases were excluded, such as sickle cell 
disease, malaria and hookworm infestation. The HIV 
virus may impair the survival and proliferative capacity 
of haematopoietic progenitor cells that differentiate to 
produce the peripheral blood cells8, in addition to blunt-
ing production of erythropoietin in anaemic HIV-
infected patients, similar to the suppression seen in other 
states of chronic infection or inflammation16. 



















Total WBC (× 109/L) 7.19 (2.09) 9.40 (4.86) 3.25 0.002 
Neutrophils (× 109/L) 2.88 (1.08) 3.72 (2.83) 2.14 0.036 
Lymphocytes(× 109/L) 3.88 (1.72) 4.52 (2.58) 1.59 0.11 
Platelets (×109/L) 325(892.4) 336(162.3) 2.12 0.037 
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dren in this study but only mild anaemia was observed 
in the controls. A similar observation was made in a 
systematic review from a global perspective involving 
fifteen studies, where mild and moderate anaemia were 
more prevalent with HIV infection in both western ad 
tropical settings, constituting 73% to 100% of cases17. 
There was no documented case of severe anaemia in this 
study probably because majority of the subjects were in 
WHO clinical stages 1 and 2. However, a study by 
Adetifa in Lagos, Nigeria15, reported severe anaemia of 
5.9% in their study. This increase in severity of anaemia 
observed in their study could be due to the fact tha sig-
nificant numbers of the subjects involved in their study 
were those with Centers for Disease Control (CDC)-
defined AIDS (stage C); anaemia severity tends to in-
crease with advancing HIV disease18-20. 
 
Higher prevalence of leucopenia (12%) and neutropenia 
(13%) were observed in HIV-infected children than in 
controls, while lymphocytopenia was seen in 3.3% of 
infected but in none of the controls. Similarly, Angeli 
etal noted leucopenia in 32 of 74 (43%) and lymphocy-
topenia in 59 of 74 (78%) in children with advance HIV 
infection in New York.21Also another study in US by 
Zon and Groopman reported 13% prevalence of neutro-
penia in asymptomatic HIV-seropositive patients andin 
44% of those with frank CDC-defined AIDS75. There-
fore, decrease of all types of white blood cells can occur 
in children with HIV infection, especially in those with 
advanced disease19. Because HIV causes decreased col-
ony growth of the committed progenitor cell, CFU-GM, 
leading to decreased production of both granulocytes, 
monocytes and other types of white blood cells19. 
Thrombocytopenia was observed more in infected chil-
dren than the controls. Also previous studies in children 
demonstrated thrombocytopenia in those with HIV in-
fection22, 23. Possible aetiologies of thrombocytopenia in 
patients with HIV infection include immune-mediated 
destruction, thrombotic thrombocytopenic purpura,  
impaired haematopoiesis4-8. 
 
Even though anaemia in HIV infection could be caused 
by a variety of pathophysiologic mechanisms, however, 
in tropical areas where malaria infection is endemic, and 
other co-morbidities like parasitic infestations, vitamins 
and micronutrient deficiencies are important considera-
tions. Therefore, effective treatment and prevention of 
these common causes of anaemia should nevertheless 
not be overlooked. This can be achieved through health 
education, hygiene and sanitation, use of insecticide-
impregnated bed nets, and discouraging children from 
walking barefoot outdoors. Parents should be advise to 
introduce vitamins and micronutrients rich food to their 
infected children. 
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